Search Results 1161-1170 of 18722 for hepatitis

1. A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination with Crizotinib - Mayo Clinic

   Known history of human immunodeficiency virus (HIV) or seropositive test for hepatitis C virus or hepatitis B virus. Participating Mayo Clinic locations.

2. A Study to Evaluate the Safety and Effectiveness of BMS-986036 (pegbelfermin) in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Fibrosis - Mayo Clinic

   ... hepatitis C virus infection (see Appendix 3), autoimmune hepatitis, drug-induced hepatotoxicity, Wilson disease, α-1-antitrypsin deficiency, iron overload ...

3. A Phase 3, randomized, open-label, controlled study comparing the efficacy and safety of zanidatamab to trastuzumab, each in combination with physician’s choice chemotherapy, for the treatment of participants with metastatic HER2-positive breast cancer - Mayo Clinic

   Participants positive for hepatitis C antibody are eligible only if polymerase chain reaction is negative for hepatitis C RNA. Has an active SARS-CoV-2 ...

4. Primary Sclerosing Cholangitis Clinical Trials - Mayo Clinic Research

   ... hepatitis (AIH), overlap AIH with Primary Biliary Cirrhosis (AIH-PBC), overlap AIH with Primary Sclerosing Cholangitis (AIH-PSC), and drug-induced ...

5. A Study to Evaluate the Safety, Tolerability, and Determine the Optimal Dose for the Expansion Cohorts of VSV-IFNβ-NIS in Combination with Pembrolizumab in Patients with Refractory Solid Tumors - Mayo Clinic

   Acute hepatitis B or acute hepatitis C. Patients with chronic hepatitis B or hepatitis C may be enrolled provided their liver function is adequate as per ...

6. A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis - Mayo Clinic

   Hepatitis status: Diagnosis of chronic hepatitis B, as evidenced by positive Hepatitis B surface antigen (HBsAg) at Screening (Visit 1). Japan only ...

7. A Study of DFRF4539A in Patients with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Positive for hepatitis B, hepatitis C or HIV infection; Pregnant or lactating women or women who intend to become pregnant within the period of time of this ...

8. Rituximab and hyaluronidase human, recombinant (subcutaneous route) - Side effects & uses - Mayo Clinic

   Hepatitis B, history of or; Kidney problems or; Lung problems (including lung tumor)—May make these conditions worse. Electrolyte or fluid imbalance or ...

9. A Study to Evaluate the Safety, Tolerance and Anti-tumor Activity of SAR442257 in Patients with Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Non-Hodgkin Lymphoma - Mayo Clinic

   Active hepatitis A, B, and C as defined below: active hepatitis A (defined as positive IgM), active hepatitis B (defined as either positive hepatitis B ...

10. A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough (CALM-2) - Mayo Clinic

    ... hepatitis B virus surface antigen, or hepatitis C virus. - Previous participation in a BLU-5937 trial. Note: Other protocol defined Inclusion/Exclusion ...